Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of rosuvastatin 20 mg tablet vs Crestor 20 mg tablet in healthy Thai volunteers (fasting, crossover)
TCTR20200617004Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Sep 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rosuvastatin in hypercholesterolemia, combined dyslipidaemia and cardiac morbidity (2 arms), sponsored by Bio-innova. Planned start Sep 2020; status: not yet recruiting.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemiacombined dyslipidaemiacardiac morbidity
Beyond the preview
Go deeper on TCTR20200617004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200617004.